Base period - AD92

Ended Awarded Last action

Contract number
0018
Awardee
Awarding agency
Obligated
$4,226,740

Award facts

Opportunity
Contract value 100% obligated
$4,226,739.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Great Britain, United Kingdom

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 9 · Inhalational ciprofloxacin for improved protection against biowarfare agents $0
Funding Only Action 8 · Research and development project to study inhalation ciproflaxacin for improved protection against biowarfare agents. $20,152
Supplemental Agreement for work within scope 7 · Research and development project to study inhalation ciprofloxacin for improved protection against biowarfare agents. $450,000
Exercise an Option 6 $550,000
Funding Only Action 5 $425,000
Funding Only Action 4 $125,000
Funding Only Action 3 $431,819
Other Administrative Action 2 · Inhalational ciprofloxacin for improved protection against biowarfare agents. -$350,000
Funding Only Action 1 · Base period $850,000
Original award $1,724,769

About this award

This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract, valued at $4,226,739.50, supports the "BASE PERIOD - AD92" requirement and has an ultimate completion date of June 26, 2021. The contract is not designated as a set-aside.

The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $146.3 million that DSTL holds with the National Institute of Allergy and Infectious Diseases (NIAID). This IDC covers the provision of pre-clinical research models for evaluating countermeasures against infectious agents, including RNA viruses with pandemic potential, antimicrobial-resistant infections, emerging infectious diseases, and neglected tropical diseases. DSTL's expertise in delivering complex, high-quality scientific research services to U.S. federal agencies is demonstrated through this significant contract vehicle.

Quick answers

Who was awarded contract 0018?

0018 was awarded to Ministry Of Defence by Defense Threat Reduction Agency (Department of Defense) on June 20, 2016.

How much is contract 0018 worth?

The government has obligated $4,226,740 on 0018.

Is contract 0018 an order under another contract?

Yes. 0018 is a delivery order under HDTRA112D0003, an indefinite delivery contract.

Was contract 0018 competed?

The extent of competition for 0018 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award